Endpoints News Announces the 2024 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
September 27 2024 - 7:00AM
Business Wire
Endpoints News, the biopharma industry’s source for breaking
news, exclusive reporting and smart analysis, today unveiled this
year’s Endpoints 11 winners — honoring the most exciting biotech
startups of 2024.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240927576694/en/
This year’s list includes several artificial intelligence
startups trying to reinvent drug R&D, though doing so with very
different approaches. It highlights the growth of China’s biotech
industry, despite the country’s tensions with the US. Four of the
winners are taking new approaches to huge disease categories
including inflammation and immunology, obesity and neuroscience.
And others are working on advanced technologies for rare ailments,
operating at the forefront of editing biology.
“We spent days debating dozens of finalists from around the
globe. This year’s group of Endpoints 11 winners represents some of
the biggest and most interesting bets happening in biotech,” said
Endpoints News Executive Editor Drew Armstrong.
The winners of the 2024 Endpoints 11 awards are:
- Lifordi Immunotherapeutics
- Mirador Therapeutics
- Formation Bio
- Xaira Therapeutics
- MediLink Therapeutics
- Iambic Therapeutics
- Ascidian Therapeutics
- Capstan Therapeutics
- Seaport Therapeutics
- Metsera
- Cardurion Pharmaceuticals
Winners of the awards were honored last night at a ceremony in
Boston. Full profiles on the winners were published this morning on
endpts.com and are available here. A look back at the outcomes of
Endpoints’ prior picks, including IPOs and M&A exits, is
available here.
About Endpoints
Endpoints News is the biopharma industry’s trusted news
authority. As part of the Financial Times’ FT Specialist group,
Endpoints publishes daily newsletters, delivers top-tier reporting
on its website, hosts industry-leading events and builds products
connecting and informing sophisticated business audiences. For more
information, visit www.endpts.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240927576694/en/
Drew Armstrong Executive Editor drew@endpointsnews.com